Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Bourgeois, Amandine Le
[Clear All Filters]
2021
Jullien M
,
Orvain C
,
Berceanu A
,
Couturier M-A
,
Guillaume T
,
Peterlin P
,
Garnier A
,
Le Bourgeois A
,
Klemencie M
,
Schmidt A
, et al.
Early Post-Transplant Serum Ferritin Levels Predict Survivals in Recipients of Haploidentical Stem Cell Transplantation Using PTCY as GVHD Prophylaxis.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
Guillaume T
,
Thépot S
,
Peterlin P
,
Ceballos P
,
Le Bourgeois A
,
Garnier A
,
Orvain C
,
Giltat A
,
François S
,
Le Bris Y
, et al.
Prophylactic or preemptive low-dose azacitidine and donor lymphocyte infusion to prevent disease relapse following allogeneic transplantation in patients with high risk acute myeloid leukemia or myelodysplastic syndrome.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
2022
Jullien M
,
Le Bourgeois A
,
Coste-Burel M
,
Peterlin P
,
Garnier A
,
Rimbert M
,
Imbert B-M
,
Le Gouill S
,
Moreau P
,
Mahe B
, et al.
B-cell aplasia is the most powerful predictive marker for poor humoral response after BNT162b2 mRNA SARS-CoV-2 vaccines in recipients of allogeneic hematopoietic stem cell transplantation.
Transplant Cell Ther. 2022.
PubMed
Google Scholar
2023
Le Bourgeois A
,
Jullien M
,
Garnier A
,
Peterlin P
,
Béné MC
,
Guillaume T
,
Chevallier P
.
Post-transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced-intensity conditioning allotransplant.
Clin Transl Med. 2023;13(4):e1242.
PubMed
Google Scholar